Whether or not patients with prostate cancer with adverse pathological features (APF) following radical prostatectomy should be offered radiotherapy immediately or wait for a high PSA reading has been a topic of controversy. Here, Adam Dicker, MD, PhD, FASTRO, of Thomas Jefferson University, Philadelphia, PA, presents the arguments for each side of the debate. This video was recorded at the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA.
APF in prostate cancer patients following radical prostatectomy: what happens next?
